1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. RemeGen Co., Ltd.
  6. News
  7. Sector news
    9995   CNE1000048G6

REMEGEN CO., LTD.

(9995)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-11 am EDT
54.20 HKD   +5.34%
08/03RemeGen to Purchase $4.4 Million of Wealth Management Products
MT
07/22RemeGen to Purchase Wealth Management Products from Qingdao Bank for $11.8 Million
MT
07/05RemeGen Invests $14 Million in Wealth Management Products
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Therapeutic Drugs
08/10HC Wainwright Lowers BioNTech SE's Price Target to $272 From $283, Maintains Buy Rating
MT
08/09European ADRs Move Higher in Tuesday Trading
MT
08/09Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups
RE
08/09Goldman Sachs Cuts BioNTech SE's Price Target to $200 From $209, Keeps Neutral Rating
MT
08/09INSIDER SELL : Regeneron Pharmaceuticals
MT
08/09INSIDER SELL : Regeneron Pharmaceuticals
MT
08/09BIONTECH : Berenberg reiterates its Buy rating
MD
08/09BIONTECH : Buy rating from Berenberg
MD
08/09Berenberg Bank Adjusts BioNTech's Price Target to $312 From $350, Maintains Buy Rating
MT
08/09BIONTECH : Goldman Sachs remains Neutral
MD
08/09EU Health Agency Starts Real-time Review of Pfizer-BioNTech's Variant-specific COVID-19..
MT
08/08SECTOR UPDATE : Health Care Stocks Getting Late Boost Back to Positive Ground
MT
08/08SECTOR UPDATE : Health Care Stocks Edging Lower This Afternoon
MT
08/08SECTOR UPDATE : Health Care
MT
08/08BioNTech Q2 Profit, Revenue Decline; Shares Drop
MT
08/08Morgan Stanley Raises Vertex Pharmaceuticals' Price Target to $253 From $250, Maintains..
MT
08/08UBS Adjusts Vertex Pharmaceuticals Price Target to $335 From $327, Maintains Buy Rating
MT
08/08European ADRs Move Higher in Monday Trading
MT
08/08TRENDING : BioNTech Expects Demand Increase in 4Q Despite Lower Earnings
DJ
08/08SECTOR UPDATE : Health Care Stocks Edge Higher Early Monday
MT
08/08BioNTech ADRs Fall 10% On Lower 2Q Revenue
DJ
08/08BioNTech Seeks Acquisitions
CI
08/08TRANSCRIPT : BioNTech SE, Q2 2022 Earnings Call, Aug 08, 2022
CI
08/08Equities Signal Stronger Session in US as More Earnings Eyed; Asia Mixed, Europe Higher
MT
08/08Wall Street Leans Forward Pre-Bell; Futures Green, Europe Up, Asia Uneven
MT
08/08BioNTech Flags Possible October Distribution of Omicron-targeted Vaccine; Shares Down 6..
MT
08/08BioNTech Logs H1 Profit Growth Following COVID-19 Vaccine Leadership
MT
08/08BioNTech SE Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
CI
08/08BioNTech Reiterates Revenue Guidance for the Full Year 2022
CI
08/08ANALYST RECOMMENDATIONS : Cigna, Duke Energy, Vertex Pharmaceuticals, EOG Resources, Motor..
MS
08/08BioNTech Reports Lower 2Q Earnings, But Sees Demand Uptick in 4Q
DJ
08/05Goldman Sachs Adjusts Price Target for Vertex Pharmaceuticals to $389 From $368, Mainta..
MT
08/05HC Wainwright Raises Vertex Pharmaceuticals Price Target to $300 From $275, Maintains B..
MT
08/05BioNTech, Genmab Expand Cancer Treatment Collaboration to Address Malignant Solid Tumor..
MT
08/05Barclays Adjusts Price Target on Vertex Pharmaceuticals to $307 From $291, Reiterates O..
MT
08/05RBC Raises Price Target on Vertex Pharmaceuticals to $278 From $269, Maintains Sector P..
MT
08/05Genmab, BioNTech Expand Cancer Therapy Collaboration
MT
08/05Genmab, BioNTech Expand Research Partnership for Cancer Treatments
DJ
08/04TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Vertex Pharmaceuticals Reports Higher Q2 Adjusted Profit, Revenue; Lifts 2022 Product R..
MT
08/04Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q2 EPS $3.60
MT
08/04Vertex Pharmaceuticals Incorporated Reports Earnings Results for the Second Quarter and..
CI
08/04Vertex Pharmaceuticals Incorporated Reports Unaudited Intangible Asset Impairment Charg..
CI
08/04EARNINGS REACTION HISTORY : Vertex Pharmaceuticals, 50.0% Follow-Through Indicator, 2.4% S..
MT
08/04Goldman Sachs Increases Regeneron Pharmaceuticals' Price Target to $796 From $790, Main..
MT
08/04UBS Adjusts Gilead Sciences Price Target to $65 From $63, Maintains Neutral Rating
MT
08/04Morgan Stanley Raises Regeneron Pharmaceuticals' Price Target to $625 From $619, Mainta..
MT
08/04Gilead Sciences to Buy UK Biotech Firm MiroBio for $405 Million
MT
08/04RBC Raises Price Target on Regeneron Pharmaceuticals to $647 From $640, Maintains Secto..
MT
08/04Gilead Sciences, Inc. entered into a definitive agreement to acquire MiroBio Ltd from S..
CI
1  2  3  4  5  6  7  8  9  10Next